Who are Alpha Tau Medical Ltd.'s main suppliers?

Alpha Tau Medical Ltd. (DRTS) key suppliers include: Matinas BioPharma Holdings, Inc.. View the full supplier network at chainsifter.com/chain/DRTS.

Who are Alpha Tau Medical Ltd.'s major customers?

Alpha Tau Medical Ltd. (DRTS) key customers include: Actinium Pharmaceuticals, Inc., Actinium Pharmaceuticals, Inc., AstraZeneca PLC, AstraZeneca PLC, Bristol-Myers Squibb Co and 10 more. View the full customer network at chainsifter.com/chain/DRTS.

What sector is Alpha Tau Medical Ltd. in?

Alpha Tau Medical Ltd. (DRTS) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Alpha Tau Medical Ltd. Supply Chain Data (DRTS): 19 Verified Relationships

1Suppliers

15Customers

3Debt Items

20Related Chains

Source-Backed Evidence Depth

Alpha Tau Medical Ltd. (DRTS) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

20Total relationships

1Distinct source URLs

4High confidence

0.751Average confidence

2026-10-28Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Alpha Tau Medical Ltd. Suppliers

Ticker	Name	Confidence	Evidence
MTNB	Matinas BioPharma Holdings, Inc.	72%	Reciprocal relationship from MTNB graph: Reciprocal relationship from DRTS graph: Reciprocal relationship from MTNB graph: Vice President, Head of Global Legal Affairs of Wockhardt Limited (2008-2012…

Alpha Tau Medical Ltd. Customers

Ticker	Name	Confidence	Evidence
ATNM	Actinium Pharmaceuticals, Inc.	72%	e term sheets, effective for a 15-year term following the approval to sell our products, Medison will be responsible for performing regulatory submissions, marketing and distribution directly to clin…
ATNM	Actinium Pharmaceuticals, Inc.	72%	Reciprocal relationship from ATNM graph: Reciprocal relationship from DRTS graph: Reciprocal relationship from ATNM graph: Reciprocal relationship from DRTS graph: e term sheets, effective for a 15-y…
AZN	AstraZeneca PLC	72%	e term sheets, effective for a 15-year term following the approval to sell our products, Medison will be responsible for performing regulatory submissions, marketing and distribution directly to clin…
AZN	AstraZeneca PLC	72%	Reciprocal relationship from AZN graph: Reciprocal relationship from DRTS graph: e term sheets, effective for a 15-year term following the approval to sell our products, Medison will be responsible f…
BMYMP	Bristol-Myers Squibb Co	72%	e term sheets, effective for a 15-year term following the approval to sell our products, Medison will be responsible for performing regulatory submissions, marketing and distribution directly to clin…
BMYMP	Bristol-Myers Squibb Co	72%	Reciprocal relationship from BMYMP graph: Reciprocal relationship from DRTS graph: e term sheets, effective for a 15-year term following the approval to sell our products, Medison will be responsible…
BSX	Boston Scientific Corporation	72%	Reciprocal relationship from BSX graph: Reciprocal relationship from DRTS graph: Reciprocal relationship from BSX graph: Reciprocal relationship from DRTS graph: e term sheets, effective for a 15-yea…
BSX	Boston Scientific Corporation	72%	e term sheets, effective for a 15-year term following the approval to sell our products, Medison will be responsible for performing regulatory submissions, marketing and distribution directly to clin…
CATX	Perspective Therapeutics, Inc.	72%	e term sheets, effective for a 15-year term following the approval to sell our products, Medison will be responsible for performing regulatory submissions, marketing and distribution directly to clin…
CATX	Perspective Therapeutics, Inc.	72%	Reciprocal relationship from CATX graph: Reciprocal relationship from DRTS graph: e term sheets, effective for a 15-year term following the approval to sell our products, Medison will be responsible …
NBTX	Nanobiotix S.A.	72%	Reciprocal relationship from NBTX graph: Reciprocal relationship from DRTS graph: Reciprocal relationship from NBTX graph: Reciprocal relationship from DRTS graph: Reciprocal relationship from NBTX g…
NBTX	Nanobiotix S.A.	72%	e term sheets, effective for a 15-year term following the approval to sell our products, Medison will be responsible for performing regulatory submissions, marketing and distribution directly to clin…
TLX	Telix Pharmaceuticals Limited	72%	Reciprocal relationship from TLX graph: Reciprocal relationship from DRTS graph: e term sheets, effective for a 15-year term following the approval to sell our products, Medison will be responsible f…
TLX	Telix Pharmaceuticals Limited	72%	e term sheets, effective for a 15-year term following the approval to sell our products, Medison will be responsible for performing regulatory submissions, marketing and distribution directly to clin…
CAPITAL-RESOURCES	CAPITAL-RESOURCES	62%	ct to continue to incur additional costs associated with operating as a public company. As a result, we will need substantial additional funding to support our continuing operations and pursue our gr…

Alpha Tau Medical Ltd. Debt Obligations

Instrument	Description	Confidence	Evidence
DRTS-DEBT	Debt stack $13.7M	90%	Market cache reports total debt of $13.7M.
DRTS-DEBT-9139	Warrants outstanding: 15891984	90%	xbrl warrant detail from xbrl 2024-12-31.
DRTS-DEBT-9140	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2022-12-31.

Alpha Tau Medical Ltd. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Alpha Tau Medical Ltd..

Alpha Tau Medical Ltd. Ownership

Holder	Name	Confidence	Evidence
DRTS-OWNER-HIGHTOWER-ADVISORS-LLC	HighTower Advisors, LLC	90%	13F overlay lists HighTower Advisors, LLC as top holder; 53 tracked holders.

Alpha Tau Medical Ltd. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
CLRB	Cellectar Biosciences, Inc.	100.00	2
BCAX	Bicara Therapeutics Inc.	100.00	2
CATX	Perspective Therapeutics, Inc.	100.00	1	['customer']
CTMX	CytomX Therapeutics, Inc.	100.00	2
CTNM	Contineum Therapeutics, Inc.	100.00	2
ALNY	Alnylam Pharmaceuticals, Inc.	100.00	2
BSX	Boston Scientific Corporation	100.00	1	['customer']
ALLO	Allogene Therapeutics, Inc.	100.00	2
ANL	Adlai Nortye Ltd.	100.00	2
BEAM	Beam Therapeutics Inc.	100.00	2
BNRG	Brenmiller Energy Ltd	100.00	2
CCCC	C4 Therapeutics, Inc.	100.00	2
AZN	AstraZeneca PLC	100.00	1	['customer']
CRBP	Corbus Pharmaceuticals Holdings, Inc.	100.00	2
CHRS	Coherus Oncology, Inc.	100.00	2
DEO	Diageo plc	100.00	2
EMMA	Emmaus Life Sciences, Inc.	100.00	2
ATNM	Actinium Pharmaceuticals, Inc.	100.00	1	['customer']
EDIT	Editas Medicine, Inc.	100.00	2
SDGR	Schrödinger, Inc.	100.00	2

Alpha Tau Medical Ltd. Supply Chain